A unique protein epitope, created by alternative-splicing of the CIZ1 gene, is present in the plasma fraction of blood from patients with lung cancer, making it a strong candidate for high impact, high throughput early detection of lung cancer. This evidence concerns the gene CIZ1 and lung cancer.